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application of aggressive strategies of stsnt deployment leading to optimal 
results with quantitative angiogrepby. The clinical benefit of an IVUS guided 
approach of stant deployment and of a lower cost strategy based on QCA 
guidance shoutd be compared in prospective randomized studies. 
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~ '~ ls  There Benefit From Intravsscular Ultrasound a 
When High-Pressure Stent Expansion Is Routinely 
Perform,~l Prior to Ultrasound Imaging? 
Stsven L. Goldberg, Patrick Hall, Shigeru Nakamura, Luigi Malelfo, 
Yaron AImagor, Jonathan Tobis, Antonio Colombo. Contro Coors 
Columbus, Milan, Italy, Harbor-UCLA Medical Center, Torrance, CA 
When high-pressure balloon inflations (HPBrs) are routinely performed ur- 
ing stent deployment, itis unclear if intravascular ultrasound (IVUS) imaging, 
adds any additional benefit. A rotmspective analysis was performed of 305 
consecutive lesions slanted with IVUS guidance after HPBrs. IVUS criteria 
for optimal slanting was: 1 ) Intrastent cross-sectional rea (CSA) was > dis- 
tal "normal" lumen CSA, and 2) No potential f ow-limiting lesions proximal or 
distal to the stented segment ware seen. "IVUS improvement" was defined 
as 1) > 25% increase in intrastent CSA when further inflations were made 
due to findings from IVUS, or 2) ,stenting of a potentially flow-flmifing lesion 
proximal or distal to the stented segment, identified by IVUS. Results: The 
mean inflation pressure prior to IVUS was 14.7 4- 3.2 arm. Only 47% of 
stectsd lesions were identified as optimal by the first IVUS imaging. CSA 
increased from 6.94 4- 2.02 mrn ~ at the time of the first IVUS imaging to 8.04 
4- 1.93 mme when finished (p < 0.001). "IVUS improvement" was seen in 
39%: 26% (8,3/315) with an increase in CSA >_ 25% and 16% (51/315) with 
additional slanting for disease identified by IVUS as potentially flow-limiting. 
Conclusion: IVUS imaging after high-pressure bell~on inflation inside 
slants demonstrates optimal results in only 47% of lesions. WUS-guidance 
leads to significant improvements in anatomic appearance 39% of the time. 
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~5-1  IS Intravascular Necessary Ultrasound Guidance 
When Using the Johnson-Johnson Slant Without 
Anticeagutation 
Christopher M. Goods, Larry S. Dean, Ming W. I_iu, Khaled F. AI-Shalbi, 
Srirem S. lyero J. Michael Parks, Ronald J, Sutor, Gary S. Roubin. University 
of Alabama at Birmingham, Birmingl;am, AL 
Between 9/94 and 8/95, 95 patients (pts) had Johnson-Johnson stents ira. 
pianted in native coronary arteries. Eighty two pts receiving 114 stents were 
s,~!scted to receive antiplatelet therapy only, 73 pts were treated with Aspirin 
and "riclopidine and 9 lots with Aspirin alone. Patients were selected for an- 
flplaletet therapy based on angiogmphic riteria, i.e. no significant residual 
stanosls, uncovered issection, tilling defect, or outflow obstruction following 
high pressure balloon inflations. Intravascular ultrasound was not used to 
assist in this process. Indications for stenting were suboptimal rosuifs (25 
lots), lesion restenosis (7 tots), ostlal lesions (26 pts) and de-novo stenting 
(24 pts). The vessel slanted was the LAD (31 pts), RCA (45 pts), LCX (6 pts) 
and LM (6 pts). Forty four pts received biliary stents. The average stent size 
was 3.49 4- 0.36 ram, range 3-5 ram. 
Results: Thhly day follow up was available in all eligible pts (n = 77). No 
pt had slant thrombosis. There were no deaths or Q-wave myocardial infarc- 
tions and no pt required bypass surgery. Non-Q-wave myocardial infarction 
occurred in 2 nts (2.4%). Bleeding requiting blood transfusion occurred In 
one pt (1.2%/. 
Conclusion: In this group of pts, stent thrombosis did not occur and the 
incidence of comorbldify was low. Intravascular ultrasound increases pro- 
cedural time and cost and appears to be unnecessary before removing 
anticoagulalion from post stsnflng protocols. 
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~ An~lography Versus Intravsscular 
Ultrasound-Dirscted Stent Placement 
Robert J. Russo, Paul S. Talrstein, for the A.V.I.D. Investigators. Scripps 
Clinic and Research Foundation, La Jcila, CA 
In the A.V.I.D. [Angiography vs. Inlravascular Ultrasound (IVUS)-Dlrected 
Stent Placement] muificenter trial, patient outcome after IVUS-directed stent 
placement is compared to stent placement directed by angiogrspby. After 
an optimal angiographic result is obtained, patients are randomized to an- 
giography or tVUS-directed therapy. In the angiogrephy arm, blinded IVUS is 
performed and the patient discharged on aspirin 325 rag/day and ticlopidine 
500 rag/day for 4 weeks. In the tVUS-directed arm, patients who fail IVUS 
crltsri:-'; are treated with larger balloons. Patients who fulfill IVUS criteria (< 
10% stenosie and full slant apposition) am discharged on aspirin and tiolopl- 
dine. Patients who fail IVUS or anglogrephlc riteria receive enoxapadn (70 
mg/day) for 2 weeks in addition to aspirin and ticlopidine. Endpoints include 
stent thrombosis, death, MI, urgent bypass or repeat intervention within 30 
days and target lesion revascularlzation at6 and 12 months. To date, 163 pa- 
tients have been randomized and 136 am eligible for 30-day follow-up. Mean 
length of stay is 1.88 days :1:1.44 in the IVUS group and 1.46 days :1:0.96 in 
the angingraphy group (p = ns). In the IVUS group, 33% of patients required 
additional therapy to fulfill IVUS criteria. At 30-day follow-up, 2 pts (2.9%) in 
the angiography group and 1 (1.5%) in the IVUS group experienced acute 
in-hospital stsnt thrombosis (p ,, ns); 1 pt (1.4%) in the anglography group 
died and none in either group required urgent bypass or repeat intervention. 
Conclusion: To date, IVUS-directed stent implantation has not influenced 
the 30-day clinical event rate; 6- and 12-roonth follow-up is pending. 
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~9~-]  Macrophages, Smooth Muscle Cells and Tissue 
Factor in Unstable Angina: Implications for Cell 
Mediated Thrambogenicity in Acute Coronary 
Syndromes 
Pedro R. Moreno, MD, Victor H. Bemardi, MD, Julio Lopoz-Cualtsr, MD, Igor 
R Palaclos, MD, Herman K. Gold, MD, Yale Nemerson, MD, Valantin Fuster, 
MD, PhD, John T. Fallon, MD, PhD. Massachusetts General Hospital, 
Boston, MA; Harvard Medical School, Boston, MA; Cardiovescular Institute, 
New York, New York, Mount Sinai School of Medicine, New York, New York 
Macrophagas (MACS) and smooth muscle cells (SMC) have been implicated 
in the pathophvsiology of acute coronary syndromes. The lipid-rich atherema- 
tous gruel is a potent hmmboganio subetrate and macrophage xpression of 
tissue factor (1"[=), mw be responsible for its thrombogeniclty. SMC may be 
involved in the thrombotic response of lesions without plaque n~ture. This 
study was designed to identify cellular correlations ol TF content in coronary 
plaque tissue from patients with unstable angina. Computerized planimetry 
was used for systematic quantification of tissue charactedstiss of 50 direc- 
tional coronary atherectomy specimens from patients with unstable angina. 
Total and segmental areas (mt~) were identified with trichrome staining and 
Included coitagon-fich sclerotic tissue, hyperoellular tissue, fibroceflular tis- 
sue, atherornstous gruel and thrombus. MACS, SMC and TF were identified 
with monoclonal antibody (KP-1), alpha actin and polyclonal TF antibody re- 
spectively. A total of 1207 pieces of tissue were quantified. Multiple stepwise 
regression analysis showed that coronary TF content could be predicted 
reliably (r = 0.83, P < 0.0001) on the basis of MACS and SMC plaque areas. 
Colocalization analysis in the atherometous gruel demonstrated a strong 
relationship between TF content and MACS areas (r ,- 0.98, P < 0.0001). 
These results show that TF content in coronary plaque tissue correlated 
with areas of MACS and SMC. Furthermore, TF content in the alheromatous 
gruel is probably mediated by MACS suggesting a call-mediated thrombo- 
genicify in patients with acute cerenary syndromes. 
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~ 2 7  Fibrinogen and C-rosstlve Protein Are Strong 
Prognostic Markers in Unstable Coronary Artery 
Disease 
Henrik Toss, Agoeta Slegbohn 1, tars Wallentln. Dept. of Cardiology, 
Uppsala, Sweden; 1 Clin. Chemistry, University Hospital, Uppsala, Sweden 
A total of 546 patients were included in a randomized, placebo controlled, 
double blind, multicantsr study evaluating the effect of daltspadn, a low 
molecular weight hsparin, in unstable coronmy artery disease, i.e. unstable 
angina bectoris or non-Q-wave AMI. Patients with newly developed or in- 
creased angina pectoris during the last two months, and with latest episode 
CRP mg/L Fib. g/L 
< 7 > 7 p < 3.58 > 3.58 p 
(n = 269) (n - 273) (n = 275) (n = 271 )
d,~0 Death 0.7 3.7 < 0.05 0 4.4 < 0.001 
% +AMI 6.3 10.3 0.1 5.8 11.1 < 0.05 
d 150 Death 2.2 8.1 < 0.01 2.9 7.4 < 0.05 
% +AMI 11.9 18.7 < 0.05 11.3 19,6 < 0.01 
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of chest-pain within 72 hours, or ongoing chest-pain, were included. ECG cd- 
teda to be fulifiged was transient or parsiel;ng ST-daprecsion and/or T-wave 
inversion. Subcutaneos injections of dalteparin 120 IU/P,g were given twice 
dally tha first 6 days followed by 7500 IU once daily the following 3.5-45 days. 
P-tibdnogen (Fib.) and P-CRP were measured at inclusion. Event rates (%) 
duflng the 150 days follow-up period were evaluated in relation to median 
levels of fibdnogen and CRR 
Conclusion: In patients with unstable coronary artery disease initially 
treated with daitepafln, and long term treatment with aspirin, elevation of 
fibfinngen and CRP at admission indicates an increased risk of subsequent 
acute myocardial infarction and death. The importance of inflammation as a 
pathological component in unstable coronary artery syndromes needs further 
evalnelion. 
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~ C-Reactive Protein In Unstable Angina: Lack of 
Asso©lation With lechemle Activity or Complex 
Lesion Morphology 
Deven J. Patel, Charles J. Knight, Nicolas A. Chronos, Colin Salisbury, 
Dabble Clarke, Chdstina Wdght, Alison H. Goodall I, Kim Fox. Royal 
Brompton Hospital, London, UK; I Royal Free Hcspital, London, UK 
C-reactive protein (CRP), a sensitive marker of inflammation, is elevated in 
unstable angina (UA) although it is not known whether a high CRP relates 
to ischaemio activity or complex lesion moqohciogy (CLM). CRP levels were 
measured, (Beckman turbidimetdc method), in 7210ts (53 males), mean age 
63.6 (46-79) yrs,with refractory UA (Braunwald class IIIB), Transient myocar- 
dial ischemia (TMI) was detected using continuous ST segment monitoring 
and angiogrephic analysis was performed by two observers blinded tO other 
study data. Median CRP was 0.89 mg/dl (0.48-20.75), and was elevated (> 
1 mg/dl) in 32 (44%) pts. TMI was present in 20 (28"/0) pts despite maximal 
medical therapy. 14 (19%) pts had 1 vessel disease, 22 (31°/=) 2vessel, and 
36 (50%) 3 vessel disease. CLM was present in 35 (49%) pts and thrombus 
in 7 (10%), Pts with TMI had similar CRP levels and was raised In a similar 
proportion (see table). Pts with CLM had similar CRP levels, although CRP 
was higher in 10ts with muifi-vessel disease (P < 0.05). CRP was raised in 
4/7 (57%) pts with thrombus. 
CRP TMI No TMI CLM No CLM 1 VD 2 VD 3 VD 
> 1 mg/dl 8 24 15 27 4 7 21 
(%) 140%) (46°/=) (43%) (46%) (29%) (32%) (58%) 
Median 0.8 0,95 0.74 0.99 0.69 0.68 1,12 
(range) 0.5-21 0.5-7.9 0.5-21 0.5-7.9 0.5-7.9 0.5"-21 0.5-20 
Conclusion Although CRP is elevated in refractory unstable angina, and is 
associated with multi-vessel disease, it does not predict ischemic activity or 
angiographic markers of acute plaque rupture. 
2:45 
~-" ]  Inflammation & Thrombosle in Unstable Angina. 
Insights From Directional Coronary Atherectomy 
Tissue Analyses 
Samin K. Sharma, Bitlie S. Fyfe, Ram Bongu, Jonathan D. Marmur, 
Sdnivas Duvvuri, Thomas R Cocke, John A. Ambrose. Mount Sinai 
Hospital, NY 
Plaque disruption with thmmbus (I") is the major pathogenetic mechanism for 
the acute coronary syndromes of myocardial infarction and unstable angina 
(UA). Recently, clinical studies have snggesled a role for Inflammation i UA. 
The relationship between inflammation and thrombus in UA has not been well 
studied. Analysis of tissue from directional atherectomy specimens can be 
used to correlate inflammation and thrombus. Thus, we analyzed the results 
of Immunohistechemical staining for maorophages (KP-1) in 54 culpdt lesions 
(19 with rest angina, 15 with new onset/crescendo, 10 post-infarction and 
10 with stable angina. Thrambus was detected by H and E staining. KP-1 
20] I I 
17/27 p<0,003 
60- 
KP-1 (+) 1 KP-1 (-) 
staining was graded as 0 to 2+ and 2+ was considered positive(+). Pathologic 
specimens were analyzed blindly. 
Thrombus was found predominantly inrest angina and post-Infarction. KP- 
1 staining was more common in ell syndromes other than stable. A positive 
KP-1 was significantly associated with thmmbus particularly in rest angina 
and post-infarction where 14 of 17 KP-1 posifive Jesions were positive for 
thrombus. Thus, these data suggest a strong association between inflamma- 
tion and thmmbus in unstable rest angina and post-infarcflon. 
3:00 
Measu.mme.nt of Leukocyte Seqm:~tration and 
Adhesion Molecule Expression in the Coronary 
Circulation of Unstable Angina Patients 
Robsrto R. Giraldez, Carlos V. Serrano, Beth Noble, Pamela Ouyang, 
David Bush, Roy Ziegelstain, Jay L Zweler. The Johns Hopk/ns Mad/cat 
Institutions, Balfimom, MD 
Polymorphonuclear leukocyte, PMN, adhesion and activation has been 
damonstmted to be of great importance in the mechanisms of myocardial 
ischamia nd reperfusion injury. Evidence from animal models demonstrates 
that upon activation by inflammatory mediators, PMNs are trapped in the 
coronary circulation. Despite the important role of PMNs in postischamio 
injury, little is known concerning the accumulation of these cells in the hesrt 
after interaction with unstable plaques. This study evelusted the magnitude 
of PMN sequestration i  the coronary circulation of unstable angina (UA) 
patients and the changes in the expression of adhesion molecules caused 
by interaction with active lesions. Ten UA patients undergoing catheteriza- 
tion within the first 48 hours of symptoms and four control patients (Ct) had 
blood samples collected simultaneously from the aorta (Ao) and coronary 
sinus (CS) pdor to the injection of contrast medium. PMN counts revealed 
a small but significant decrease in the number of coils collected in the CS 
compared to the Ao (p < 0.05). PMNs also had typical L-selectin (activation 
associated) shedding (p = 0.001). This pattern of activation, however, was 
not paralleled by CDllb and CD18 adhesion molecules, suggesting that cells 
which had this integrin upreguletion remained sequestered ue to adhesion 
to the coronary endothelium. 
Group Coronary Sinus 
Cell Count L-setectfn CDllb COl8 
UA(n=10) 0.93 :E 0.03" 0.79 ~: 0.05"* 1.04 d:0.12 0.88 :E 0.1 
ct (n -4) 0.99 ± 0.03 1,04 :t: 0,01 1.00 ± 0.05 0.98 ± 0.03 
Resu~ expressed as % of ¢ontm! (Ao measurements);'p < 0.05, **p - 0.001 
Thus, in unstable angina L-seleotin shedding and PMN accumulation oc- 
curs within the coronary circulation which may in turn contribute to further 
vascular or myocardial damage. 
3:15 
~ Plesminogen Activation in Unstable Angina Is 
Associated WRIt an Acute Phase Response but Not 
With Activation of the Her~estestic System 
Luigi M. Biasueci, Giovanna Liuzzo, Gaetano Quaranta, Laura Massa, 
Giusepplna Caliglufi, Claudia Monaco, Francasco Summaria, Willy van de 
Gresf, Antonio G. Rebuzzi, Comalis Kluft 1, Attilio Masen. C, ard/otogy 
Institute, UCSC.Rome, Italy; I PG.TNO Gaubius Inst. Leiden, NL 
Coronary thrombosis i  the major pathngeceflc event leading to ischemia in 
pts with unstable angina (UA). This event invokes the coagulation and the 
tibdnolytic systems, and, possibly, the inflamrrt~tory s stem. To assess the 
role of activation of tibrynolytic system and its relation with the hemestatic 
and the inflammatory s stems, we messursd plasma levels of Plasmin.~2- 
antilolasmin (PAP), C-Reactive protein (CRP) and Thrombin-Anh'Thmmbin 
Ifl (TAT), as markers of plesminogen act;va~n, inflammation and thrombin 
production, respectively. We also measured plasma levels of D-Dimer (DD), 
a tibdn degradation product, to assess actual lysis of fibrin. We studied 
pts admitted to our CCU for severe UA, Blood samples were taken at 
CCU admission. As controls(C) we studied 20 healthy volunteers. Resu~ 
(median and range): Elevated levels were considered above mean +2 SO 
for PAP (700 ng/ml), DD (70/~g/I) and TAT (4 p.g/ml) and levels > 3 mg/I 
for CRP (9O~percentile of healthy subjects), Elevated levels of PAP were 
observed in 16/32 pts (50%), but elevated levels of DD and TAT were found 
only in 5/32 pts (16%). Conversely CRP was raised in 23132 pts (71.8%). 
PAP levels were significantly higher in pts with UA than in C (698 ng/ml, 
range 268-1899 vs 413 ng/ml, range 201-826; p = 0.017) but they did 
not correlate with levels of DD (20.3/zg/I, range 5.7-246; r = 0,06, p = 
ns) or of TAT (2.1 p.g/ml, range 0.95-23, r = -0.05, p = as). Conversely 
a significant correlation was observed between PAP and CRP (4.55 rag/l, 
range 0.7-82; r = 0.47, p = 0.005). Conclusions: In pts with UA there is a 
